Merck & Co., Inc.·4

May 2, 4:11 PM ET

Williams David Michael 4

4 · Merck & Co., Inc. · Filed May 2, 2024

Insider Transaction Report

Form 4
Period: 2024-04-30
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-30+16,40616,406 total
    Exercise: $129.22From: 2025-04-30Exp: 2034-04-29Common Stock (16,406 underlying)
Holdings
  • Common Stock

    19,875.918
Footnotes (2)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT